Brain-Targeted Nanoparticles with Cancer Cell Membrane Coating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery systems struggle to cross the blood-brain barrier, limiting the treatment of central nervous system diseases due to the barrier's restrictive nature, necessitating an efficient delivery method for conditions like Alzheimer's, Parkinson's, and brain tumors.
Innovation Solution
Nanoparticles with a biocompatible core and a shell derived from brain metastatic cancer cell membranes are developed to facilitate transport across the blood-brain barrier, using materials like poly(lactic-co-glycolic acid) and active agents such as doxorubicin, enabling targeted delivery of CNS disorder treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drug delivery systems are used, then the drugs can be administered systemically, but they cannot cross the blood-brain barrier effectively
Solution Approach 1:
The patent uses cell membrane-coated nanoparticles as intermediary carriers. The nanoparticles serve as the delivery vehicle while the cell membrane coating acts as a mediator that facilitates crossing the blood-brain barrier. The membrane coating provides surface properties that enable interaction with the barrier, allowing the encapsulated drug to be transported across the blood-brain barrier into the brain tissue.
Solution Approach 2:
The patent employs composite nanoparticle structures consisting of a core material (polymer or inorganic) coated with a cell membrane. This composite structure combines the drug-encapsulating capability of the nanoparticle core with the barrier-crossing ability of the cell membrane coating, creating a hybrid delivery system that overcomes the blood-brain barrier restriction.
2Reliability
If nanoparticle size is reduced to improve BBB penetration, then crossing ability increases, but loading capacity decreases
Solution Approach 1:
The patent implements a nested structure where the drug-loaded nanoparticle core is encapsulated within a cell membrane coating. The nanoparticle core contains the therapeutic agent, and this core is then nested within the membrane layer. This nested configuration allows the small nanoparticle to penetrate the blood-brain barrier while the core maintains sufficient volume for adequate drug loading.
Solution Approach 2:
The patent applies different functional properties to different parts of the nanoparticle system. The cell membrane coating provides the surface properties necessary for BBB penetration and cellular interaction, while the nanoparticle core provides the encapsulation volume for drug loading. Each component is optimized for its specific function, allowing small size for penetration while maintaining adequate loading capacity through the core structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles effectively cross the blood-brain barrier, as demonstrated by increased cellular uptake and in vivo imaging, enhancing the delivery of therapeutic agents to brain tissues, thereby improving treatment outcomes for various CNS disorders.
Implementation Method 1
increased cellular uptake and in vivo imaging
Data Source
AI summary
A nanoparticle suitable for delivery of an active agent across the blood-brain barrier is provided. As such, the nanoparticle can target brain tissue so that the active agent can be delivered across the blood-brain barrier to the target brain tissue. The nanoparticle includes a core that includes a core material such as a polymer or inorganic material as well as an active agent; and a shell comprising a membrane derived from a brain metastatic cancer cell, wherein the brain metastatic cancer cell facilitates transport of the nanoparticle across a blood-brain barrier. Also disclosed are methods of forming the nanoparticle and methods of using the nanoparticle.